At present, Boston Scientific Corp. (BSX) has a stock price of $54.76. In the previous session, the stock saw a rise, peaking at $54.58 after an opening price of $54.06. The day’s lowest price was $54.05, and it closed at $54.46.
Boston Scientific Corp. saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $55.38 on 09/20/23, while the lowest price for the same duration was marked at $42.73 on 11/22/22.
52-week price history of BSX Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Boston Scientific Corp.’s current trading price is -1.12% away from its 52-week high, while its distance from the 52-week low is 28.15%. The stock’s price range during the 52-week period has remained between $42.73 and $55.38. In the Healthcare sector, the company’s shares saw a trading volume of around 1.36 million for the day, which was evidently lower than the average daily volume of 8.52 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Boston Scientific Corp. (BSX) has experienced a quarterly rise of 8.76% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 80.22B and boasts a workforce of 45000 employees.
A Closer Look at Analysts’ Ratings for Boston Scientific Corp.
As of right now, 23 analysts are rating Boston Scientific Corp. as a BUY, 5 of the polled analysts branded the stock as an OVERWEIGHT, 4 analysts are recommending to HOLD this stock, 1 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 52.19, with a change in price of +0.67. Similarly, Boston Scientific Corp. recorded 7,792,508 in trading volume during the last 100 days, posting a change of +1.23%.
Examining BSX’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for BSX stands at 0.49. Similarly, the long-term debt-to-equity ratio is also 0.47.
BSX Stock Stochastic Average
Boston Scientific Corp.’s raw stochastic average for the past 50 days is presently 91.11%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 95.49%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 91.46% and 90.93%, respectively.
BSX Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Year to date metric has recorded a gain of 18.35%.However, over the last six months, we can see a weaker performance of 6.33%. Over the last 30 days, the price of BSX has fallen by 9.24%. And in the last five days, it has surged by 1.37%.